Work

A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdn745

Authors: M.A. Socinski, M.N. Saleh, D.F. Trent, T.W. Dobbs, L.M. Zehngebot, M.A. Levine, R. Bordoni, P.J. Stella

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Georgia Cancer Specialists, Virginia Cancer Institute, Tennessee Cancer Specialists, Florida Hospital Cancer Institute, Greater Baltimore Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2142042045

FWCI: 6.451

Cites: 23

Cited by: 38

Related to: 10